Biotage AB
STO:BIOT
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BIOT's stock price target?
Not Available
BIOT doesn't have any price targets made by Wall Street professionals.
What is Biotage AB's Revenue forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Biotage AB's revenue is
13%.
The projected
CAGR
for the next 3 years is
7%.
What is Biotage AB's Operating Income forecast?
Projected CAGR
16%
For the last 13 years the
compound annual growth rate for
Biotage AB's operating income is
23%.
The projected
CAGR
for the next 3 years is
16%.
What is Biotage AB's Net Income forecast?
Projected CAGR
17%
For the last 13 years the
compound annual growth rate for
Biotage AB's net income is
18%.
The projected
CAGR
for the next 3 years is
17%.
